- Home
- ABEO vs TEI Comparison
ABEO vs TEI Comparison
Compare ABEO & TEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- TEI
- Stock Information
- Founded
- ABEO N/A
- TEI 1993
- Country
- ABEO United States
- TEI United States
- Employees
- ABEO N/A
- TEI N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- TEI Finance Companies
- Sector
- ABEO Health Care
- TEI Finance
- Exchange
- ABEO Nasdaq
- TEI Nasdaq
- Market Cap
- ABEO 243.9M
- TEI 242.3M
- IPO Year
- ABEO 1980
- TEI N/A
- Fundamental
- Price
- ABEO $5.19
- TEI $5.23
- Analyst Decision
- ABEO Strong Buy
- TEI
- Analyst Count
- ABEO 3
- TEI 0
- Target Price
- ABEO $18.00
- TEI N/A
- AVG Volume (30 Days)
- ABEO 251.8K
- TEI 142.4K
- Earning Date
- ABEO 11-14-2024
- TEI 01-01-0001
- Dividend Yield
- ABEO N/A
- TEI 10.51%
- EPS Growth
- ABEO N/A
- TEI N/A
- EPS
- ABEO N/A
- TEI N/A
- Revenue
- ABEO N/A
- TEI N/A
- Revenue This Year
- ABEO N/A
- TEI N/A
- Revenue Next Year
- ABEO $15,721.96
- TEI N/A
- P/E Ratio
- ABEO N/A
- TEI N/A
- Revenue Growth
- ABEO 147.52
- TEI N/A
- 52 Week Low
- ABEO $3.05
- TEI $4.35
- 52 Week High
- ABEO $9.01
- TEI $5.39
- Technical
- Relative Strength Index (RSI)
- ABEO 34.35
- TEI 49.77
- Support Level
- ABEO $5.05
- TEI $5.08
- Resistance Level
- ABEO $5.66
- TEI $5.29
- Average True Range (ATR)
- ABEO 0.27
- TEI 0.06
- MACD
- ABEO -0.06
- TEI 0.02
- Stochastic Oscillator
- ABEO 13.21
- TEI 71.43
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About TEI Templeton Emerging Markets Income Fund Inc.
Templeton Emerging Markets Income Fund is a closed-end fund. It seeks high, current income, with a secondary goal of capital appreciation, by investing, under normal market conditions. The company's investment portfolio includes Foreign Government and Agency Securities; Quasi-Sovereign and Corporate Bonds; Common Stocks and Other Equity Interests, and Short-Term Investments and Money Market Funds.